WASHINGTON--(BUSINESS WIRE)--High quality, low cost generic pharmaceuticals made in India and the United States want the truth known across America, retaining India First Group, LLC to set the record straight - promoting the benefits of affordable access to medicine as vital to improving healthcare worldwide.
India First Group is tasked to mobilize the Coalition for Affordable Care, which aims to counter one of the most anti-Indian, negative advocacy campaigns ever witnessed in the two countries’ history. Forces backed by Big Pharma, including the most powerful special interest business lobby in the United States, PhRMA, chaired by Pfizer’s Ian Reid, the Global Intellectual Property Center of the U.S. Chamber of Commerce, and the National Association of Manufacturers, continue their campaign to downgrade the reputation of Indian pharmaceuticals in order to maintain market share and destroy competition.
Like David against Goliath, the Coalition for Affordable Care - with inner strength and moral authority - will aim to blunt this special interest offensive.
India First Group’s mission, under the leadership of former U.S.-India Business Council President, Ron Somers, will be to mobilize like-minded constituents who support access to low cost, high quality alternatives to what has become a cocktail of unaffordable branded medicines. Because of the excessive, high price of these medicines, treatment for most of the world’s population is now beyond the reach of even the common man.
“With more and more American 'Baby-Boomers' requiring access to lower cost, high quality medical treatments and medicines, they join most of the world’s population – some 5 billion people - finding themselves unable to afford even basic care. The time has come to let the truth be known on Capitol Hill, in the halls of government, and across America, that Indian and U.S. manufacturers of generic drugs are producing high quality medicines at a fraction of the price of branded pharmaceuticals. Short-sighted tactics and negative campaigns may have worked to preserve market share for these special interests previously, but history is not on their side,” says India First Group’s Ron Somers.
Coalition for Affordable Care stakeholders support market-based pricing and the protection of intellectual property in line with global norms. Constituents like the Indian Pharmaceutical Alliance, comprised of such prominent companies as Sun, Lupin, Dr. Reddy’s Labs, Zydus Cadila, Ranbaxy, among many others, are busy developing new drug discoveries and health treatments for their product pipelines. And when mass production at highest quality with cost in mind is paramount, like when President George W. Bush called on world-wide producers to help battle AIDS in Africa, it was India’s pharmaceutical companies that made quality anti-retrovirals, enabling PEPFAR in Africa to succeed - one of the triumphant humanitarian successes of the George W. Bush Administration.
Insurers seeking to lower costs, pension funds, large employers, doctors, healthcare professionals – essentially all generations of Americans born after 1930 who now find themselves unable to afford basic healthcare, will be invited to join the Coalition for Affordable Care, a statement said.
Forces desperate to squelch competition such as PhRMA, GIPC, and NAM, which have had a free run tar-brushing India these past twelve months while that country has been busy with its recent national elections, will face fresh resistance now – as India’s new Prime Minister, Narendra Modi, will be focused on growing India’s economy, where public health and the need for affordable healthcare figure prominently.
India First Group, LLC (www.IndiaFirstGroup.com) is a strategic advisory firm based in Washington, DC and New Delhi which assists U.S. companies pursuing business opportunities in India, and supports Indian companies investing in the United States. The Coalition for Affordable Care is comprised of like-minded stakeholders whose core aim is to promote access to high quality, low cost medicines to improve quality of life globally. The Indian Pharmaceutical Alliance is based in India and consists of India’s finest branded pharmaceutical companies which manufacture the highest quality, low cost medicines, enabling access to these medicines to hundreds of millions of users daily.